Member Exclusive
Cell and Gene Therapy Catapult manufacturing center receives new investment
A £12 million award from the UK Government’s Industrial Strategy Challenge Fund will double the capacity of the Cell and Gene Therapy Catapult manufacturing center in Stevenage, UK.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
- Connect and collaborate with other members
- Post about your own research, share your take on key topics and more
1 Comments
Given these exciting resource developments, we at Asymmetrex hope that Catapult stem cell therapy process engineers with visit http://asymmetrex.com/our-serv... and get us involved as essential partners in their future endeavors to accelerate development of new stem cell-based therapies that use natural tissue stem cells. We have the best tools for manufacturing tissue stem cells specifically, instead of the more abundant non-stem committed cells that always accompany them.
James L. Sherley, M.D., Ph.D.
Founder and Director, Asymmetrex